MXPA04006125A - Utilizacion de desoxipeganina en el tratamiento de la depresion clinica. - Google Patents
Utilizacion de desoxipeganina en el tratamiento de la depresion clinica.Info
- Publication number
- MXPA04006125A MXPA04006125A MXPA04006125A MXPA04006125A MXPA04006125A MX PA04006125 A MXPA04006125 A MX PA04006125A MX PA04006125 A MXPA04006125 A MX PA04006125A MX PA04006125 A MXPA04006125 A MX PA04006125A MX PA04006125 A MXPA04006125 A MX PA04006125A
- Authority
- MX
- Mexico
- Prior art keywords
- desoxypeganine
- treating clinical
- clinical depression
- depression
- treating
- Prior art date
Links
- WUFQLZTXIWKION-UHFFFAOYSA-N Deoxypeganine Chemical compound C1C2=CC=CC=C2N=C2N1CCC2 WUFQLZTXIWKION-UHFFFAOYSA-N 0.000 title abstract 2
- 208000007848 Alcoholism Diseases 0.000 abstract 1
- 206010012289 Dementia Diseases 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 206010043903 Tobacco abuse Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 206010001584 alcohol abuse Diseases 0.000 abstract 1
- 208000025746 alcohol use disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000012458 free base Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10163667A DE10163667B4 (de) | 2001-12-21 | 2001-12-21 | Verwendung von Desoxypeganin zur Behandlung der klinischen Depression |
| PCT/EP2002/014274 WO2003053445A1 (de) | 2001-12-21 | 2002-12-14 | Verwendung von desoxypeganin zur behandlung der klinischen depression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA04006125A true MXPA04006125A (es) | 2005-05-16 |
Family
ID=7710660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA04006125A MXPA04006125A (es) | 2001-12-21 | 2002-12-14 | Utilizacion de desoxipeganina en el tratamiento de la depresion clinica. |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US20050009813A1 (enExample) |
| EP (1) | EP1461042B1 (enExample) |
| JP (1) | JP2005513105A (enExample) |
| KR (1) | KR100614504B1 (enExample) |
| CN (1) | CN1283253C (enExample) |
| AR (1) | AR037967A1 (enExample) |
| AT (1) | ATE404203T1 (enExample) |
| AU (1) | AU2002363874B2 (enExample) |
| BR (1) | BR0215306A (enExample) |
| CA (1) | CA2471338C (enExample) |
| CZ (1) | CZ301210B6 (enExample) |
| DE (2) | DE10163667B4 (enExample) |
| DK (1) | DK1461042T3 (enExample) |
| EA (1) | EA006896B1 (enExample) |
| ES (1) | ES2312657T3 (enExample) |
| HU (1) | HUP0402298A3 (enExample) |
| IL (2) | IL162509A0 (enExample) |
| MX (1) | MXPA04006125A (enExample) |
| MY (1) | MY138088A (enExample) |
| NO (1) | NO326446B1 (enExample) |
| NZ (1) | NZ533249A (enExample) |
| PL (1) | PL370315A1 (enExample) |
| PT (1) | PT1461042E (enExample) |
| SI (1) | SI1461042T1 (enExample) |
| SK (1) | SK287152B6 (enExample) |
| TW (1) | TWI241189B (enExample) |
| UA (1) | UA76254C2 (enExample) |
| WO (1) | WO2003053445A1 (enExample) |
| ZA (1) | ZA200404053B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE521512C2 (sv) * | 2001-06-25 | 2003-11-11 | Niconovum Ab | Anordning för administrering av en substans till främre delen av en individs munhåla |
| ES2708552T3 (es) * | 2002-12-20 | 2019-04-10 | Niconovum Ab | Método para la preparación de un material particulado que contiene nicotina con una celulosa cristalina (en particular MCC) |
| DE10354894A1 (de) * | 2003-11-24 | 2005-07-07 | Hf Arzneimittelforschung Gmbh | Orale Formulierungen des Desoxypeganins und deren Anwendungen |
| DE10354893B4 (de) * | 2003-11-24 | 2011-03-10 | Hf Arzneimittelforschung Gmbh | Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen |
| FR2865650B1 (fr) * | 2004-01-30 | 2008-06-13 | Biocortech | Utilisation du 14,15 dihydro 20,21-dinoreburnamenin14-ol pour traiter et/ou prevenir les depressions majeures et les desordres du cycle veille-sommeil |
| JP5000932B2 (ja) * | 2005-06-21 | 2012-08-15 | 日東電工株式会社 | ニコチン含有経皮吸収製剤 |
| WO2007104573A2 (en) | 2006-03-16 | 2007-09-20 | Niconovum Ab | Improved snuff composition |
| CN101433565B (zh) * | 2008-11-26 | 2013-06-05 | 上海中医药大学 | 骆驼蓬属种子总生物碱提取物和它们的制备 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19906977C1 (de) * | 1999-02-19 | 2000-06-15 | Lohmann Therapie Syst Lts | Desoxypeganin-TTS und seine Verwendung |
| DE19906975B4 (de) * | 1999-02-19 | 2004-04-15 | Lts Lohmann Therapie-Systeme Ag | Arzneiform zur Behandlung von Alzheimer'scher Demenz |
| DE19906978B4 (de) * | 1999-02-19 | 2004-07-08 | Lts Lohmann Therapie-Systeme Ag | Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit |
| DE19906974C2 (de) * | 1999-02-19 | 2003-10-09 | Lohmann Therapie Syst Lts | Verwendung von Desoxypeganin zur Behandlung des Alkoholismus |
| DE19906979B4 (de) * | 1999-02-19 | 2004-07-08 | Lts Lohmann Therapie-Systeme Ag | Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit |
-
2001
- 2001-12-21 DE DE10163667A patent/DE10163667B4/de not_active Expired - Fee Related
-
2002
- 2002-12-12 MY MYPI20024665A patent/MY138088A/en unknown
- 2002-12-14 MX MXPA04006125A patent/MXPA04006125A/es active IP Right Grant
- 2002-12-14 PT PT02798337T patent/PT1461042E/pt unknown
- 2002-12-14 AU AU2002363874A patent/AU2002363874B2/en not_active Ceased
- 2002-12-14 SK SK258-2004A patent/SK287152B6/sk not_active IP Right Cessation
- 2002-12-14 SI SI200230755T patent/SI1461042T1/sl unknown
- 2002-12-14 UA UA20040604815A patent/UA76254C2/uk unknown
- 2002-12-14 EA EA200400751A patent/EA006896B1/ru not_active IP Right Cessation
- 2002-12-14 KR KR1020047009851A patent/KR100614504B1/ko not_active Expired - Fee Related
- 2002-12-14 BR BR0215306-8A patent/BR0215306A/pt not_active Application Discontinuation
- 2002-12-14 AT AT02798337T patent/ATE404203T1/de active
- 2002-12-14 DK DK02798337T patent/DK1461042T3/da active
- 2002-12-14 HU HU0402298A patent/HUP0402298A3/hu unknown
- 2002-12-14 WO PCT/EP2002/014274 patent/WO2003053445A1/de not_active Ceased
- 2002-12-14 US US10/496,366 patent/US20050009813A1/en not_active Abandoned
- 2002-12-14 CZ CZ20040739A patent/CZ301210B6/cs not_active IP Right Cessation
- 2002-12-14 IL IL16250902A patent/IL162509A0/xx unknown
- 2002-12-14 CA CA002471338A patent/CA2471338C/en not_active Expired - Fee Related
- 2002-12-14 NZ NZ533249A patent/NZ533249A/en not_active IP Right Cessation
- 2002-12-14 DE DE50212649T patent/DE50212649D1/de not_active Expired - Lifetime
- 2002-12-14 EP EP02798337A patent/EP1461042B1/de not_active Expired - Lifetime
- 2002-12-14 ES ES02798337T patent/ES2312657T3/es not_active Expired - Lifetime
- 2002-12-14 JP JP2003554202A patent/JP2005513105A/ja not_active Ceased
- 2002-12-14 PL PL02370315A patent/PL370315A1/xx not_active Application Discontinuation
- 2002-12-14 CN CNB028254031A patent/CN1283253C/zh not_active Expired - Fee Related
- 2002-12-17 TW TW091136439A patent/TWI241189B/zh not_active IP Right Cessation
- 2002-12-20 AR ARP020105056A patent/AR037967A1/es unknown
-
2004
- 2004-05-25 ZA ZA200404053A patent/ZA200404053B/en unknown
- 2004-06-14 IL IL162509A patent/IL162509A/en not_active IP Right Cessation
- 2004-06-14 NO NO20042476A patent/NO326446B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL300933I2 (nl) | Letermovir | |
| MXPA03010134A (es) | Derivados de ciclohexan-1-4-diamina sustituidos. | |
| MXPA03011039A (es) | Nuevos compuestos heterociclicos, su preparacion y uso como medicamentos, particularmente como agentes anti-bacterianos. | |
| WO2001030381A3 (de) | Verwendung von csf-1-inhibitoren | |
| MXPA03011515A (es) | Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos. | |
| WO2003080582A3 (de) | Fredericamycin-derivate | |
| WO2002047668A3 (de) | Neue arzneimittelkompositionen auf der basis von anticholinergika und ciclesonide | |
| YU71901A (sh) | NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA | |
| PL364598A1 (en) | Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments | |
| GB0111186D0 (en) | Novel compounds | |
| DE50305587D1 (en) | 2-heteroarylcarbonsäureamide | |
| WO2002030870A3 (de) | Substituierte c-cyclohexylmethylamin-derivate | |
| WO2004087700A8 (fr) | Derives du benzenesulfonamide, leur procede de preparation et leur utilisation de la douleur | |
| WO2003037863A3 (de) | Substituierte indole, verfahren zu deren herstellung und deren verwendung zur schmerzbekämpfung | |
| MXPA04006125A (es) | Utilizacion de desoxipeganina en el tratamiento de la depresion clinica. | |
| MXPA04000446A (es) | 4-aminociclohexanoles sustituidos. | |
| MXPA04004090A (es) | Compuestos substituidos de 1h-quinolin-2-ona. | |
| WO2001049651A3 (de) | Aminomethyl-phenyl-cyclohexanonderivate | |
| AU2003245989A1 (en) | Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases | |
| AU2002365288A1 (en) | Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases | |
| MXPA04000272A (es) | Derivados de 4-aminociclohexanol sustituidos. | |
| WO2005047278A3 (de) | Substituierte dihydrochinazoline ii | |
| AU2001277737A1 (en) | Novel substance having physiological activity, process for producing the same, and use | |
| AU2002254930A1 (en) | Novel medicament compositions based on anticholinergic agents and endothelin antagonists | |
| MY127328A (en) | 5-amino-1-pentene-3-ol substituted derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |